Aurobindo Pharma Limited
AUROPHARMA
Rank in Stocks
#2032
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Share Price
$17.67
Market Cap
$10.17B
Change (1 day)
-1.25%
Change (1 year)
41.33%
Country
IN
Trade Aurobindo Pharma Limited (AUROPHARMA)
Category
Healthcare
P/S ratio for Aurobindo Pharma Limited (AUROPHARMA)
P/S ratio as of October 2026 TTM: 2.77
According to Aurobindo Pharma Limited latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.77. At the end of 2024 the company had a P/S ratio of 2.25.
P/S ratio history for Aurobindo Pharma Limited from 2004 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 2.77 | 33.31% |
| 2025 | 2.08 | -7.36% |
| 2024 | 2.25 | 82.40% |
| 2023 | 1.23 | -26.44% |
| 2022 | 1.68 | -20.27% |
| 2021 | 2.10 | 97.49% |
| 2020 | 1.06 | -55.13% |
| 2019 | 2.37 | 10.73% |
| 2018 | 2.14 | -20.47% |
| 2017 | 2.69 | -15.48% |
| 2016 | 3.19 | 7.66% |
| 2015 | 2.96 | 59.79% |
| 2014 | 1.85 | 142.25% |
| 2013 | 0.77 | 0.21% |
| 2012 | 0.76 | -40.71% |
| 2011 | 1.29 | -11.40% |
| 2010 | 1.45 | 342.21% |
| 2009 | 0.33 | -48.77% |
| 2008 | 0.64 | -62.35% |
| 2007 | 1.70 | -24.28% |
| 2006 | 2.25 | 103.16% |
| 2005 | 1.11 | -7.07% |
| 2004 | 1.19 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 154.53% |
IN
|
